alendronate has been researched along with Albright Syndrome in 6 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of polyostotic fibrous dysplasia in a three-year-old child who showed significant improvement in bone mineral density after treatment with oral alendronate." | 1.32 | Oral bisphosphonates in polyostotic fibrous dysplasia. ( Khadilkar, AV; Khadilkar, VV; Maskati, GB, 2003) |
| "Oral alendronate is suggested to be a useful option in the treatment of polyostotic fibrous dysplasia." | 1.32 | Oral alendronate treatment for polyostotic fibrous dysplasia: a case report. ( Ito, H; Kitagawa, Y; Tamai, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, WS | 1 |
| Lee, JC | 1 |
| Jayaraman, M | 1 |
| Karikumar, K | 1 |
| Verma, A | 1 |
| Modi, KD | 1 |
| Khadilkar, VV | 1 |
| Khadilkar, AV | 1 |
| Maskati, GB | 1 |
| Kitagawa, Y | 1 |
| Tamai, K | 1 |
| Ito, H | 1 |
| Kumar, S | 1 |
| Yamamoto, T | 1 |
| Ozono, K | 1 |
| Shima, M | 1 |
| Yoshikawa, H | 1 |
| Okada, S | 1 |
6 other studies available for alendronate and Albright Syndrome
| Article | Year |
|---|---|
Fibrous dysplasia of the craniofacial bones.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Disease Progression; Facial Asymmetry; Facial B | 2013 |
Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.
Topics: Adolescent; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium Carbonate; Cholecal | 2011 |
Oral bisphosphonates in polyostotic fibrous dysplasia.
Topics: Administration, Oral; Alendronate; Bone Density; Child, Preschool; Fibrous Dysplasia, Polyostotic; H | 2003 |
Oral alendronate treatment for polyostotic fibrous dysplasia: a case report.
Topics: Administration, Oral; Alendronate; Bone Regeneration; Female; Fibrous Dysplasia, Polyostotic; Humans | 2004 |
Bisphosphonate therapy in polyostotic fibrous dysplasia.
Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Child; Fibrous Dysplasia, Polyo | 2004 |
Alendronate and pharmacological doses of 1alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia.
Topics: Adult; Alendronate; Bone and Bones; Calcium Compounds; Drug Therapy, Combination; Female; Fibrous Dy | 2002 |